GRAY SUSANNAH 4
4 · Theravance Biopharma, Inc. · Filed May 10, 2024
Insider Transaction Report
Form 4
GRAY SUSANNAH
Director
Transactions
- Award
Ordinary Shares
2024-05-08+10,537→ 31,488 total - Award
Share Option (Right to Buy)
2024-05-08+23,576→ 23,576 totalExercise: $9.49Exp: 2034-05-07→ Ordinary Shares (23,576 underlying)
Footnotes (1)
- [F1]This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the company's shareholders provided the optionee remains in continuous service on such date.